Please login to the form below

Not currently logged in
Email:
Password:

Ontruzant

This page shows the latest Ontruzant news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

This follows hot on the heels of MSD (working with Samsung Bioepsis) that launched the first Herceptin biosimilar, Ontruzant, in March.

Latest news

  • MSD launches EU’s first biosimilar Herceptin in UK MSD launches EU’s first biosimilar Herceptin in UK

    MSD launches EU’ s first biosimilar Herceptin in UK. Ontruzant is set to be strong competition for Roche’s blockbuster. ... The first biosimilar version of Roche’s blockbuster breast cancer drug Herceptin has been launched in the UK by MSD under

  • Roche faces biosimilar blitz in 2018 Roche faces biosimilar blitz in 2018

    But Roche’s cancer antibody isn’t its only drug battling for market share - breast cancer blockbuster Herceptin (trastuzmab) also has a biosimilar rival in the form of Samsung Bioepis’Ontruzant,

  • First Herceptin biosimilar cleared in Europe First Herceptin biosimilar cleared in Europe

    First Herceptin biosimilar cleared in Europe. Ontruzant is approved for all the same indications as Roche’s blockbuster. ... Ontruzant is the fourth biosimilar developed by the Korean company to receive marketing authorisation in the EU.

  • CHMP backs maintenance therapy for Tesaro's Zejula CHMP backs maintenance therapy for Tesaro's Zejula

    The CHMP recommended approval of two biosimilars, namely Samsung Bioepis' Ontruzant (trastuzumab) - the first biosimilar of Roche's breast cancer therapy Herceptin to get a positive opinion in the EU - and

  • Archive listing

    Ontruzant is set to be strong competition for Roche’s blockbuster. .

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics